224 related articles for article (PubMed ID: 33091367)
41. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
Bugge AS; Lund MB; Valberg M; Brustugun OT; Solberg S; Kongerud J
Eur J Cardiothorac Surg; 2018 Jan; 53(1):221-227. PubMed ID: 28950311
[TBL] [Abstract][Full Text] [Related]
42. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
[TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
[TBL] [Abstract][Full Text] [Related]
44. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
[TBL] [Abstract][Full Text] [Related]
45. Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.
Dillman RO; Zusman DR; McClure SE
Clin Lung Cancer; 2009 Mar; 10(2):130-4. PubMed ID: 19362957
[TBL] [Abstract][Full Text] [Related]
46. Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.
Shewale JB; Correa AM; Brown EL; Leon-Novelo LG; Nyitray AG; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Walsh GL; Roth J; Vaporciyan AA; Swisher SG; Sepesi B
Ann Thorac Surg; 2020 Feb; 109(2):404-411. PubMed ID: 31539514
[TBL] [Abstract][Full Text] [Related]
47. Covid-19 and lung cancer: A greater fatality rate?
Rogado J; Pangua C; Serrano-Montero G; Obispo B; Marino AM; Pérez-Pérez M; López-Alfonso A; Gullón P; Lara MÁ
Lung Cancer; 2020 Aug; 146():19-22. PubMed ID: 32505076
[TBL] [Abstract][Full Text] [Related]
48. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
49. Impact of the COVID-19 pandemic on non-small-cell lung cancer pathologic stage and presentation.
Keogh JAJ; Chhor AD; Begum H; Akhtar-Danesh N; Finley C
Can J Surg; 2022; 65(4):E496-E503. PubMed ID: 35926883
[TBL] [Abstract][Full Text] [Related]
50. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
51. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.
Lee PC; Korst RJ; Port JL; Kerem Y; Kansler AL; Altorki NK
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1382-9. PubMed ID: 17140961
[TBL] [Abstract][Full Text] [Related]
52. Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic.
Pulia MS; O'Brien TP; Hou PC; Schuman A; Sambursky R
Ann Med; 2020 Aug; 52(5):207-214. PubMed ID: 32370561
[TBL] [Abstract][Full Text] [Related]
53. Surgical resection of brain metastases from lung cancer.
Andrews RJ; Gluck DS; Konchingeri RH
Acta Neurochir (Wien); 1996; 138(4):382-9. PubMed ID: 8738387
[TBL] [Abstract][Full Text] [Related]
54. Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis.
Ferguson MK
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1935-42. PubMed ID: 14688709
[TBL] [Abstract][Full Text] [Related]
55. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
[TBL] [Abstract][Full Text] [Related]
56. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
57. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
58. Extent of surgery and survival in early lung carcinoma: implications for overdiagnosis in stage IA nonsmall cell lung carcinoma.
Sugarbaker DJ; Strauss GM
Cancer; 2000 Dec; 89(11 Suppl):2432-7. PubMed ID: 11147621
[TBL] [Abstract][Full Text] [Related]
59. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
[TBL] [Abstract][Full Text] [Related]
60. Outcomes After Surgery in High-Risk Patients With Early Stage Lung Cancer.
Sancheti MS; Melvan JN; Medbery RL; Fernandez FG; Gillespie TW; Li Q; Binongo JN; Pickens A; Force SD
Ann Thorac Surg; 2016 Mar; 101(3):1043-50; Discussion 1051. PubMed ID: 26572255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
